Maria Manuel Mota

Maria Manuel Mota's AcademicInfluence.com Rankings

Maria Manuel Mota

Biology

#2564

World Rank

#4042

Historical Rank

Immunology

#398

World Rank

#413

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Maria Manuel Mota Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Maria Manuel Mota is a Portuguese malariologist and executive director of the Instituto de Medicina Molecular João Lobo Antunes, Lisbon. Education Maria Mota, a native of Vila Nova de Gaia, graduated from her undergraduate degree in Biology in 1992 and received her master's degree in immunology in 1994 from the University of Porto. She received her PhD in molecular parasitology in 1998 from University College London, working at the affiliated National Institute for Medical Research with Will Jarra and Anthony Holder.

(See a Problem?)

Maria Manuel Mota's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Migration of Plasmodium sporozoites through cells before infection. (2001) (563)
Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria (2007) (519)
The silent path to thousands of merozoites: the Plasmodium liver stage (2006) (465)
Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. (2005) (308)
Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. (2005) (276)
ATLAS: Technical proposal for a general-purpose p p experiment at the Large Hadron Collider at CERN (1994) (269)
Malaria Blood Stage Suppression of Liver Stage Immunity by Dendritic Cells (2003) (254)
Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection (2013) (241)
Host-mediated regulation of superinfection in malaria (2011) (239)
Visualisation and Quantitative Analysis of the Rodent Malaria Liver Stage by Real Time Imaging (2009) (223)
A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. (2013) (187)
Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. (2008) (159)
Accumulation of Plasmodium berghei-Infected Red Blood Cells in the Brain Is Crucial for the Development of Cerebral Malaria in Mice (2010) (158)
Hepatocyte growth factor and its receptor are required for malaria infection (2003) (141)
Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. (2008) (137)
Nutrient sensing modulates malaria parasite virulence (2017) (132)
The relevance of non-human primate and rodent malaria models for humans (2011) (126)
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds (2012) (124)
Migration through host cells activates Plasmodium sporozoites for infection (2002) (117)
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens (2015) (113)
Adenylyl Cyclase α and cAMP Signaling Mediate Plasmodium Sporozoite Apical Regulated Exocytosis and Hepatocyte Infection (2008) (111)
Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events (2009) (111)
A toolbox to study liver stage malaria. (2011) (111)
HGF/MET signalling protects Plasmodium‐infected host cells from apoptosis (2005) (110)
Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug (2012) (107)
VEGF Promotes Malaria-Associated Acute Lung Injury in Mice (2010) (103)
Fluorescent Plasmodium berghei sporozoites and pre‐erythrocytic stages: a new tool to study mosquito and mammalian host interactions with malaria parasites (2001) (99)
Kinome-Wide RNAi Screen Implicates at Least 5 Host Hepatocyte Kinases in Plasmodium Sporozoite Infection (2008) (97)
A Research Agenda for Malaria Eradication: Basic Science and Enabling Technologies (2011) (96)
Human iPSC-Derived Hepatocyte-like Cells Support Plasmodium Liver-Stage Infection In Vitro (2015) (95)
Plasmodium chabaudi-Infected Erythrocytes Adhere to CD36 and Bind to Microvascular Endothelial Cells in an Organ-Specific Way (2000) (93)
Host Cell Phosphatidylcholine Is a Key Mediator of Malaria Parasite Survival during Liver Stage Infection (2014) (91)
Migration through host cells activates Plasmodium sporozoites for infection (2003) (90)
Interactions of the malaria parasite and its mammalian host. (2008) (90)
Transition of Plasmodium Sporozoites into Liver Stage-Like Forms Is Regulated by the RNA Binding Protein Pumilio (2011) (86)
Acute Plasmodium chabaudi chabaudi Malaria Infection Induces Antibodies Which Bind to the Surfaces of Parasitized Erythrocytes and Promote Their Phagocytosis by Macrophages In Vitro (1998) (85)
Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells. (2005) (83)
Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry (2007) (81)
A Novel Carbon Monoxide-Releasing Molecule Fully Protects Mice from Severe Malaria (2011) (79)
Gold nanoparticle-based fluorescence immunoassay for malaria antigen detection (2011) (75)
Plasmodium UIS3 sequesters host LC3 to avoid elimination by autophagy in hepatocytes (2017) (75)
Targeting the liver stage of malaria parasites: a yet unmet goal. (2012) (74)
Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins (2013) (73)
Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. (2007) (69)
Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay. (2009) (69)
The IFN-γ-Inducible GTPase, Irga6, Protects Mice against Toxoplasma gondii but Not against Plasmodium berghei and Some Other Intracellular Pathogens (2011) (68)
Adipose Tissue: A Safe Haven for Parasites? (2017) (67)
The Next Opportunity in Anti-Malaria Drug Discovery: The Liver Stage (2011) (67)
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs (2015) (65)
Design and Evaluation of Primaquine-Artemisinin Hybrids as a Multistage Antimalarial Strategy (2011) (63)
Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii. (2006) (62)
Cerebral malaria and the hemolysis/methemoglobin/heme hypothesis: shedding new light on an old disease. (2009) (62)
Parasite Sensing of Host Nutrients and Environmental Cues. (2018) (57)
Migration through host cells: the first steps of Plasmodium sporozoites in the mammalian host (2004) (54)
Incorporation of basic side chains into cryptolepine scaffold: structure-antimalarial activity relationships and mechanistic studies. (2011) (53)
Host cell autophagy contributes to Plasmodium liver development (2016) (53)
PSLAP, a protein with multiple adhesive motifs, is expressed in Plasmodium falciparum gametocytes. (2002) (53)
Invasion of mammalian host cells by Plasmodium sporozoites (2002) (52)
Innate Immunity Induced by Plasmodium Liver Infection Inhibits Malaria Reinfections (2015) (50)
The malaria parasite has an intrinsic clock (2020) (49)
Antimalarial drugs – host targets (re)visited (2006) (48)
Migration through host cells by apicomplexan parasites. (2001) (46)
Hypoxia promotes liver-stage malaria infection in primary human hepatocytes in vitro (2013) (45)
A vacuolar iron-transporter homologue acts as a detoxifier in Plasmodium (2016) (45)
Use of a Selective Inhibitor To Define the Chemotherapeutic Potential of the Plasmodial Hexose Transporter in Different Stages of the Parasite's Life Cycle (2011) (44)
Dietary alterations modulate susceptibility to Plasmodium infection (2017) (44)
Parasite‐induced ER stress response in hepatocytes facilitates Plasmodium liver stage infection (2015) (44)
Superinfection in malaria: Plasmodium shows its iron will (2011) (42)
In Vivo Hemozoin Kinetics after Clearance of Plasmodium berghei Infection in Mice (2012) (41)
Novel endoperoxide-based transmission-blocking antimalarials with liver- and blood-schizontocidal activities. (2014) (40)
A Novel Flow Cytometric Hemozoin Detection Assay for Real-Time Sensitivity Testing of Plasmodium falciparum (2013) (40)
Plasmodium berghei EXP-1 interacts with host Apolipoprotein H during Plasmodium liver-stage development (2017) (40)
Crystal structure of arginase from Plasmodium falciparum and implications for L-arginine depletion in malarial infection . (2010) (39)
Imidazoquines as antimalarial and antipneumocystis agents. (2009) (39)
Simple flow cytometric detection of haemozoin containing leukocytes and erythrocytes for research on diagnosis, immunology and drug sensitivity testing (2011) (37)
Unlike the synchronous Plasmodium falciparum and P. chabaudi infection, the P. berghei and P. yoelii asynchronous infections are not affected by melatonin (2009) (37)
Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry. (2013) (36)
Plasmodium Cysteine Repeat Modular Proteins 3 and 4 are essential for malaria parasite transmission from the mosquito to the host (2011) (35)
Innate recognition of malarial parasites by mammalian hosts. (2012) (35)
Survival of protozoan intracellular parasites in host cells (2004) (34)
Host AMPK Is a Modulator of Plasmodium Liver Infection (2016) (32)
Malaria infections: what and how can mice teach us. (2014) (32)
Malaria Vaccines: Back to the Future? (2005) (31)
Infection by Plasmodium changes shape and stiffness of hepatic cells. (2012) (31)
A Plasmodium berghei sporozoite-based vaccination platform against human malaria (2018) (30)
Targeting host factors to circumvent anti-malarial drug resistance. (2012) (28)
Highly Dynamic Host Actin Reorganization around Developing Plasmodium Inside Hepatocytes (2012) (28)
Plasmodium berghei parasite transformed with green fluorescent protein for screening blood schizontocidal agents. (2004) (28)
Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection (2007) (28)
γδ-T cells promote IFN-γ–dependent Plasmodium pathogenesis upon liver-stage infection (2019) (27)
A Small Molecule Inhibitor of Signal Peptide Peptidase Inhibits Plasmodium Development in the Liver and Decreases Malaria Severity (2009) (27)
Chemical Interrogation of the Malaria Kinome (2014) (26)
Plasmodium yoelii: efficient in vitro invasion and complete development of sporozoites in mouse hepatic cell lines. (2000) (26)
Genistein-Supplemented Diet Decreases Malaria Liver Infection in Mice and Constitutes a Potential Prophylactic Strategy (2008) (25)
Antibody Recognition of Rodent Malaria Parasite Antigens Exposed at the Infected Erythrocyte Surface: Specificity of Immunity Generated in Hyperimmune Mice (2001) (24)
Cross-Species Immunity in Malaria Vaccine Development: Two, Three, or Even Four for the Price of One? (2007) (24)
Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria. (2013) (22)
Targeting liver stage malaria with metformin. (2019) (21)
Towards a Humanized Mouse Model of Liver Stage Malaria Using Ectopic Artificial Livers (2017) (21)
Malaria Liver Stage Susceptibility Locus Identified on Mouse Chromosome 17 by Congenic Mapping (2008) (21)
Infection by and protective immune responses against Plasmodium berghei ANKA are not affected in macrophage scavenger receptors A deficient mice (2006) (20)
Unveiling the pathogen behind the vacuole (2015) (19)
Early skin immunological disturbance after Plasmodium-infected mosquito bites. (2012) (18)
Assessment of Dual Life Stage Antiplasmodial Activity of British Seaweeds (2013) (17)
Transcriptome profile of dendritic cells during malaria: cAMP regulation of IL‐6 (2007) (16)
Simple, sensitive and quantitative bioluminescence assay for determination of malaria pre-patent period (2014) (16)
Plasmodium berghei-infection induces volume-regulated anion channel-like activity in human hepatoma cells (2009) (15)
One nanoprobe, two pathogens: gold nanoprobes multiplexing for point-of-care (2015) (15)
Structural optimization of quinolon-4(1H)-imines as dual-stage antimalarials: toward increased potency and metabolic stability. (2013) (14)
Microbiota, a Third Player in the Host-Plasmodium Affair. (2019) (14)
Be in motion . . . (2006) (14)
Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver (2011) (13)
Phosphothioate oligodeoxynucleotides inhibit Plasmodium sporozoite gliding motility (2010) (13)
Parasitology. Malaria vaccines: back to the future? (2005) (13)
malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication (2017) (13)
Flavones as isosteres of 4(1H)-quinolones: discovery of ligand efficient and dual stage antimalarial lead compounds. (2013) (13)
To migrate or to invade: those are the options. (2007) (12)
IL-1α promotes liver inflammation and necrosis during blood-stage Plasmodium chabaudi malaria (2019) (12)
Disrupting Plasmodium UIS3–host LC3 interaction with a small molecule causes parasite elimination from host cells (2020) (10)
Plasmodium translocon component EXP2 facilitates hepatocyte invasion (2020) (10)
Severe malaria increases the list of heme oxygenase-1-protected diseases. (2007) (10)
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection (2021) (10)
In Vitro Alterations Do Not Reflect a Requirement for Host Cell Cycle Progression during Plasmodium Liver Stage Infection (2014) (10)
A spatiotemporally resolved single cell atlas of the Plasmodium liver stage (2021) (8)
Metabolic competition between lipid metabolism and histone methylation regulates sexual differentiation in human malaria parasites (2022) (8)
Targeting Plasmodium host cells: survival within hepatocytes. (2004) (8)
2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes. (2014) (7)
Plasmodium falciparum subtilisin‐like ookinete protein SOPT plays an important and conserved role during ookinete infection of the Anopheles stephensi midgut (2018) (6)
Association of Plasmodium berghei With the Apical Domain of Hepatocytes Is Necessary for the Parasite's Liver Stage Development (2020) (5)
The relevance of host genes in malaria. (2018) (5)
The Cytoplasmic Prolyl-tRNA Synthetase of the Malaria Parasite is a Dual-Stage Target for Drug Development (2015) (5)
Parasitism: Anopheles Mosquitoes and Plasmodium Parasites Share Resources (2019) (4)
Plasmodium parasitophorous vacuole membrane-resident protein UIS4 manipulates host cell actin to avoid parasite elimination (2021) (4)
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance (2022) (4)
A mediator for malaria stickiness in A versus O blood (2015) (4)
Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal (2021) (4)
A Novel Chemically Differentiated Mouse Embryonic Stem Cell-Based Model to Study Liver Stages of Plasmodium berghei (2020) (4)
The crucial role of hepatocyte growth factor receptor during liver-stage infection is not conserved among Plasmodium species (2011) (3)
The reciprocal influence of the liver and blood stages of the malaria parasite's life cycle. (2022) (3)
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic (2021) (3)
Immune Response to Infection and Vaccination (2017) (3)
Biology of the Malaria Parasite – editorial on the special issue for the 10th BioMalPar conference (2014) (2)
Active APPL1 sequestration by Plasmodium favors liver-stage development. (2022) (2)
Innate Immunity to Malaria (2017) (2)
New pieces for the malaria liver stage puzzle: where will they fit? (2008) (2)
Reply to Rénia et al. (2006) (2)
Perspective: Hidden treasures from the archives (2009) (2)
Simple, sensitive and quantitative bioluminescence assay for determination of malaria pre-patent period (2014) (1)
Prevalence of a type-I interferon immune response against malaria liver stage infection (2010) (1)
The Hepatocyte as a Household for Plasmodium Parasites (2020) (1)
Host lung microbiota promotes malaria-associated acute respiratory distress syndrome (2022) (1)
Interplay between liver and blood stages of Plasmodium infection dictates malaria severity via γδ T cells and IL-17-promoted stress erythropoiesis. (2023) (1)
InVivo Hemozoin Kinetics after Clearance of Plasmodiumberghei Infection inMice (2014) (1)
SR-BI is a crucially required host factor with a dual role in the establishment of malaria liver infection. (2008) (1)
Plasmodium invasion of mosquito cells: hawk or dove?: Response from Mota and Rodrı́guez (2001) (1)
liberating carbon monoxide molecules ruthenium and uses thereof (2012) (0)
Be in motion . . . (2006) (0)
Malaria sporozoite: migrating for a living. Authors' reply (2004) (0)
The Nobel Prize for the Insulin Discovery. (2021) (0)
Immunosupression in malaria: A role for apoptosis? (1997) (0)
Atomic Force Microscopy for the Characterisation of the Effects and Treatment of Infectious Parasites (2013) (0)
Plasmodium UIS3 sequesters host LC3 to avoid elimination by autophagy in hepatocytes (2017) (0)
Cover Picture: Chemical Interrogation of the Malaria Kinome (ChemBioChem 13/2014) (2014) (0)
Malaria sporozoite: migrating for a living – a response (2004) (0)
ATOMIC FORCE MICROSCOPY AND FLUORESCENCE MICROSCOPY OF MALARIAL HEPATOCYTES (2008) (0)
Structure of Plasmodium falciparum Arginase in complex with ABH (2010) (0)
Malaria Molecule Fully Protects Mice from Severe A Novel Carbon Monoxide-Releasing (2012) (0)
More on adaptive or innate resistance to Plasmodium. (1999) (0)
A Plasmodium berghei sporozoite-based vaccination platform against human malaria (2018) (0)
Interview no. 1270 (2005) (0)
Portugal, Armitage, Newbold, Drakesmith and Mota reply (2011) (0)
Gold Nanoparticle-Based Immunoassay for detection of Plasmodium falciparum Hsp70 (2010) (0)
Reply to: Hepcidin in malaria superinfection: can findings be translated to humans? (2011) (0)
Phagocytosis by Macrophages In Vitro Erythrocytes and Promote Their Which Bind to the Surfaces of Parasitized Malaria Infection Induces Antibodies Plasmodium chabaudi chabaudi Acute (2012) (0)
The nutrient games - Plasmodium metabolism during hepatic development. (2023) (0)
ORGANIZADORES GHIT ANALYSIS OF THE RACIAL PROFILE OF WOMEN WITH COVID-19: CROSS-SECTIONAL STUDY ABOUT EVOLUTION TO DEATH OF BLACK WOMEN IN THE SOUTHEAST REGION OF BRAZIL (0)
Characterizing Iron transporters in Plasmodium species Aparajita Lahree 2015 (2015) (0)
Disrupting Plasmodium UIS3–host LC3 interaction with a small molecule causes parasite elimination from host cells (2020) (0)
Dual role of type I IFN during plasmodium infection (P3056) (2013) (0)
A non-canonical sensing pathway mediates Plasmodium adaptation to amino acid deficiency (2023) (0)
IL-1α promotes liver inflammation and necrosis during blood-stage Plasmodium chabaudi malaria (2019) (0)
Fighting for Resources: Who Started the Battle? Who Is Winning It? (2018) (0)
Growth curve of Plasmodium falciparum (3D7) after treatment with pyrimethamine. (2013) (0)
A Plasmodium berghei Sporozoite-Based Vaccination Platform Against 3 (2018) (0)
Developmental transition of Plasmodium sporozoites into liver-stage forms is regulated by the RNA binding protein Pumilio 2 (2010) (0)
Plasmodium-Host-Plasmodium interactions (2010) (0)
Dietary alterations modulate susceptibility to Plasmodium infection (2017) (0)

This paper list is powered by the following services:

Other Resources About Maria Manuel Mota

en.wikipedia.org

What Schools Are Affiliated With Maria Manuel Mota?

Maria Manuel Mota is affiliated with the following schools: